Geist Volker, Sherif Mohammad A, Khattab Ahmed A
Herz-Kreislauf-Zentrum, Segeberger Kliniken GmbH, The Academic Teaching Hospital for the University of Kiel, Bad Segeberg, Germany.
Catheter Cardiovasc Interv. 2009 Jan 1;73(1):61-7. doi: 10.1002/ccd.21744.
The association between aortic valve disease and coronary atherosclerosis is common. In the recent era of percutaneous aortic valve replacement (PAVR), there is little experience with coronary artery intervention after valve implantation.
To our knowledge, this is the first case of successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve. We report a case of a 79-year-old female patient who underwent successful coronary artery intervention few months after a CoreValve's percutaneous implantation for severe aortic valve stenosis. Verifying the position of the used wires (crossing from inside the self expanding frame) is of utmost importance before proceeding to coronary intervention. In this case, crossing the aortic valve, coronary angiography, and multivessel stenting were successfully performed.
Percutaneous coronary intervention in patients with previous CoreValve is feasible and safe.
主动脉瓣疾病与冠状动脉粥样硬化之间的关联很常见。在最近的经皮主动脉瓣置换术(PAVR)时代,瓣膜植入后进行冠状动脉介入治疗的经验很少。
据我们所知,这是首例在植入CoreValve经皮主动脉瓣后成功进行经皮冠状动脉介入治疗的病例。我们报告一例79岁女性患者,在因严重主动脉瓣狭窄接受CoreValve经皮植入术后数月成功进行了冠状动脉介入治疗。在进行冠状动脉介入治疗之前,确认所用导丝(从自膨胀框架内部穿过)的位置至关重要。在该病例中,成功完成了穿过主动脉瓣、冠状动脉造影和多支血管支架置入术。
既往有CoreValve植入史的患者进行经皮冠状动脉介入治疗是可行且安全的。